Aptose Biosciences
APTO
#10464
Rank
C$6.03 M
Marketcap
C$2.36
Share price
0.00%
Change (1 day)
735.26%
Change (1 year)

Aptose Biosciences (APTO) - Net assets

Net assets on the balance sheet as of March 2025 : -C$10.22 Million

According to Aptose Biosciences's latest financial reports the company has -C$10.22 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Aptose Biosciences - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2023-12-31$-C$3.85 Million-107.51%
2022-12-31$C$51.21 M-45.87%
2021-12-31$C$94.6 M-37.6%
2020-12-31$C$0.15 B23.6%
2019-12-31$C$0.12 B539.55%
2018-12-31$C$19.18 M49.54%
2017-12-31$C$12.82 M30.25%
2016-12-31$C$9.84 M-48%
2015-12-31$C$18.93 M
2014-05-31$C$28.42 M-3740.11%
2013-05-31$-C$0.79 Million-61.58%
2012-05-31$-C$2.04 Million-958.92%
2011-05-31$C$0.23 M-143.72%
2010-05-31$-C$0.55 Million-93.52%
2009-05-31$-C$8.36 Million117.05%
2008-05-31$-C$3.85 Million-610.73%
2007-05-31$C$0.75 M-129.46%
2006-05-31$-C$2.56 Million-119.41%
2005-05-31$C$13.18 M-54.03%
2004-05-31$C$28.68 M-0.57%
2003-05-31$C$28.85 M-34.91%
2002-05-31$C$44.32 M-21.07%
2001-05-31$C$56.15 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Advaxis
ADXS
-C$33.75 Million 230.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
C$0.15 B-1,601.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
C$0.77 B-7,696.32%๐Ÿ‡บ๐Ÿ‡ธ USA